Younger adults · Texas
Studies for younger adults in Texas
These studies accept adults from 21 or younger and set an upper age limit of 45 or below, so they are aimed at younger adults. Being in the age range does not mean you qualify; screening decides.
63 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingHealthy volunteersPhase 1
Gamma Oscillations as a Prognostic Marker for Ketamine Therapy in Treatment Resistant Depression
Texas A&M University
- Location
- Houston, TX + 1 other US site
- Eligibility basics
- Ages 21–45
- RecruitingHealthy volunteersPhase 3
Fertilo In Vitro Research Study and Trial
Gameto, Inc.
- Location
- Addison, TX + 15 other US sites
- Eligibility basics
- Ages 18–35 · Women only
- RecruitingHealthy volunteers
Wearable Photoplethysmography for Non-invasive Hydration Assessment
PepsiCo Global R&D
- Location
- Frisco, TX + 1 other US site
- Eligibility basics
- Ages 18–45
- RecruitingHealthy volunteers
Effects of Eggshell Membrane and Curcumin Extract Supplementation, Separately or Combined, on Recovery From Intense Exercise
ESM Technologies, LLC
- Location
- College Station, TX
- Eligibility basics
- Ages 18–40 · Men only
- Recruiting
Evaluation of Orthokeratology Lenses With a 5MM Optic Zone Diameter
CooperVision International Limited (CVIL)
- Location
- Bellaire, TX + 1 other US site
- Eligibility basics
- Ages 7–35
- RecruitingPhase 3
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
Novo Nordisk A/S
- Location
- Houston, TX + 13 other US sites
- Eligibility basics
- Ages 10–18
- RecruitingPhase 2
Effect of FB301 on Vaginal Bacterial Profile in Women With Asymptomatic Vaginal Dysbiosis Undergoing a Mock Frozen Embryo Transfer Cycle
Freya Biosciences ApS
- Location
- Houston, TX + 2 other US sites
- Eligibility basics
- Ages 18–45 · Women only
- RecruitingPhase 3
A Phase 3 Study of Fenfluramine Hydrochloride in Rett Syndrome
UCB BIOSCIENCES, Inc.
- Location
- Houston, TX + 7 other US sites
- Eligibility basics
- Ages 5–35
- RecruitingPhase 3
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
Sanofi
- Location
- Houston, TX + 33 other US sites
- Eligibility basics
- Ages 1–25
- RecruitingPhase 2
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
SAb Biotherapeutics, Inc.
- Location
- Dallas, TX + 20 other US sites
- Eligibility basics
- Ages 5–40
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of Subcutaneous Nomlabofusp in Subjects With Friedreich's Ataxia
Larimar Therapeutics, Inc.
- Location
- Dallas, TX + 2 other US sites
- Eligibility basics
- Ages 12–40
- RecruitingPhase 3
A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)
Eli Lilly and Company
- Location
- Corpus Christi, TX + 3 other US sites
- Eligibility basics
- Ages 1–35
- RecruitingPhase 3
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
Eli Lilly and Company
- Location
- Fort Worth, TX + 8 other US sites
- Eligibility basics
- Ages 2–19
- RecruitingPhase 1
A Study to Assess Sulbactam-durlobactam in Pediatric Patients With Acinetobacter Baumannii-calcoaceticus Complex Infection
Innoviva Specialty Therapeutics
- Location
- Galveston, TX + 3 other US sites
- Eligibility basics
- Ages 0 mo–18
- RecruitingPhase 3
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
Novo Nordisk A/S
- Location
- Houston, TX + 26 other US sites
- Eligibility basics
- Ages 8–18
- Recruiting
SAINT in Postpartum Depression (PPD)
Magnus Medical
- Location
- Austin, TX + 3 other US sites
- Eligibility basics
- Ages 18–45 · Women only
- RecruitingPhase 3
A Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN)
Janssen Research & Development, LLC
- Location
- Austin, TX + 19 other US sites
- Eligibility basics
- Ages 18–45 · Women only
- RecruitingPhase 3
A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)
Janssen Research & Development, LLC
- Location
- Galveston, TX + 11 other US sites
- Eligibility basics
- Ages 18–45 · Women only
- RecruitingPhase 3
Human Menopausal Gonadotropin Research in Infertility Assessing Cumulative Live Birth With Frozen Embryo Transfer.
Granata Bio Corporation
- Location
- Bedford, TX + 14 other US sites
- Eligibility basics
- Ages 18–42 · Women only
- RecruitingPhase 2
A Study of Belumosudil in Children With Chronic Graft Versus Host Disease (schoolROCK)
Sanofi
- Location
- Houston, TX + 6 other US sites
- Eligibility basics
- Ages 1–18
- RecruitingPhase 3
Study of ALK-001 on the Progression of Stargardt Disease
Alkeus Pharmaceuticals, Inc.
- Location
- Dallas, TX + 11 other US sites
- Eligibility basics
- Ages 8–45
- RecruitingPhase 3
Brexanolone Lifting Outcomes Of Moms
Lipocine Inc.
- Location
- Plano, TX + 15 other US sites
- Eligibility basics
- Ages 15–45 · Women only
- RecruitingPhase 1/Phase 2
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
COUR Pharmaceutical Development Company, Inc.
- Location
- Austin, TX + 44 other US sites
- Eligibility basics
- Ages 12–35
- Recruiting
Hormone-free Antral Retrieval for Viable Embryo Storage & Transfer
Kevin Doody
- Location
- Bedford, TX
- Eligibility basics
- Ages 18–35 · Women only